Trial Profile
The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- 15 Feb 2018 New trial record
- 09 Feb 2018 Primary endpoint (Change in Total Nasal Symptom Score (TNSS) From Baseline to Post-treatment.) has not been met as per the results published in the Annals of Allergy, Asthma and Immunology
- 09 Feb 2018 Results published in the Annals of Allergy, Asthma and Immunology